The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience

Figure 4

Cumulative probability of achieving MMR on 2G-TKI treatment assessed by Hasford risk score (LR, low-risk group, IR, intermediate-risk group).